Fennec Pharmaceuticals In... (FENC)
6.78
-0.24 (-3.42%)
At close: Mar 03, 2025, 3:59 PM
6.77
-0.15%
After-hours: Mar 03, 2025, 04:00 PM EST
Fennec Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 |
| Revenue | 21.25M | 1.53M | n/a | 170K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.66 | 0.68 |
| Cost of Revenue | 1.26M | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55.23K | n/a |
| Gross Profit | 19.99M | 1.45M | n/a | 170K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55.23K | 0.68 |
| Operating Income | -12.77M | -22.59M | -17.22M | -17.89M | -13.01M | -10.41M | -6.95M | -2.87M | -1.89M | -2.88M | -1.93M | -3.62M | -3.44M | -4.6M | -3.22M | -13.89M | -14.19M | -19.06M | -18.35M | -9.42M | -6.74M | -4.04M | -2.65M | -1.61M |
| Interest Income | 441K | 195K | 54K | 87K | 322.32K | n/a | n/a | n/a | 3K | 2K | 2K | 25K | 43K | 32K | 47K | 286K | 833K | n/a | 361K | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -16.05M | -23.71M | -17.35M | -18.11M | -12.78M | -9.89M | -7.05M | -2.79M | -659K | -2.18M | 1.84M | -5.16M | 4.68M | -7.82M | -3.01M | -13.6M | -13.36M | -20.64M | -21.54M | -9.59M | -6.67M | -3.72M | -2.45M | -1.6M |
| Net Income | -16.05M | -24.84M | -17.46M | -17.92M | -12.46M | -9.89M | -7.05M | -2.79M | -659K | -2.18M | 1.84M | -5.16M | 4.68M | -7.82M | -3.01M | -13.6M | -13.36M | -19.1M | -19.25M | -8.74M | -6.15M | -3.72M | -2.45M | -1.6M |
| Selling & General & Admin | 32.71M | 20.51M | 12.24M | 12.95M | 7.4M | 5.4M | 5.01M | 2.4M | 1.63M | 2.52M | 1.33M | 1.54M | 1.94M | 3.9M | 1.21M | 3.52M | 3.28M | 2.88M | 3.18M | 3.49M | 1.78M | 907.4K | 738.72K | 614.25K |
| Research & Development | 56K | 3.53M | 4.98M | 5.11M | 5.61M | 5.01M | 1.94M | 472K | 256K | 357K | 597K | 2.08M | 1.49M | 708K | 2.11M | 10.37M | 10.91M | 14M | 12.44M | 3.59M | 3.55M | 3.13M | 1.91M | 939.36K |
| Other Expenses | n/a | n/a | n/a | -9K | -17K | 6K | -8K | -14K | n/a | n/a | -3K | -5K | n/a | n/a | n/a | n/a | n/a | 2.18M | 2.72M | 2.34M | 1.42M | n/a | 55.23K | 52.01K |
| Operating Expenses | 32.76M | 24.04M | 17.22M | 18.05M | 13.01M | 10.41M | 6.95M | 2.87M | 1.89M | 2.88M | 1.93M | 3.62M | 3.44M | 4.6M | 2.83M | 13.89M | 14.19M | 19.06M | 18.35M | 9.42M | 6.74M | 4.04M | 2.7M | 1.61M |
| Interest Expense | 3.39M | 978K | 126K | 9K | n/a | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | 11K | -444K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 12.12M | 2.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 34.02M | 24.12M | 17.22M | 18.05M | 13.01M | 10.41M | 6.95M | 2.87M | 1.89M | 2.88M | 1.93M | 3.62M | 3.44M | 4.6M | 2.83M | 13.89M | 14.19M | 19.06M | 18.35M | 9.42M | 6.74M | 4.04M | 2.65M | 1.61M |
| Income Tax | n/a | 1.13M | 110K | -187K | -315K | -348K | -47K | -8K | -3K | -2K | -2K | -25K | -43K | 7.82M | 3.01M | 13.6M | 13.36M | -1.53M | -2.29M | -854.68K | -518.2K | 3.72M | 2.45M | 1.6M |
| Shares Outstanding (Basic) | 26.57M | 26.27M | 26.01M | 23.7M | 19.9M | 18.94M | 14.99M | 12.68M | 10.83M | 9.87M | 9.72M | 8.2M | 7.99M | 7.08M | 3.07M | 3.07M | 2.79M | 1.14M | 941.26K | 580.75K | 309.64K | 192.51K | 122.02K | 536.64K |
| Shares Outstanding (Diluted) | 26.57M | 26.27M | 26.01M | 23.7M | 19.9M | 19.02M | 15.01M | 12.77M | 10.83M | 9.87M | 10.57M | 8.39M | 8.02M | 7.08M | 3.07M | 3.07M | 2.79M | 1.14M | 941.26K | 580.75K | 309.64K | 192.51K | 607.09K | 536.64K |
| EPS (Basic) | -0.6 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 | -0.47 | -0.22 | -0.06 | -0.22 | 0.19 | -0.63 | 0.59 | -1.11 | -0.98 | -4.43 | -4.78 | -16.72 | -20.45 | -15.04 | -19.85 | -19.32 | -20.12 | -2.98 |
| EPS (Diluted) | -0.6 | -0.95 | -0.67 | -0.76 | -0.63 | -0.52 | -0.47 | -0.22 | -0.06 | -0.22 | 0.17 | -0.62 | 0.58 | -1.11 | -0.98 | -4.43 | -4.78 | -16.72 | -20.45 | -15.04 | -19.85 | -19.32 | -4.04 | -2.98 |
| EBITDA | -12.36M | -22.59M | -123K | -17.89M | 234K | 521K | -95K | 82K | -1.89M | -2.88M | 1.79M | -5.18M | 4.55M | -4.6M | -2.6M | -13.89M | -14.19M | -17.91M | -19.27M | -12.56M | -5.22M | -4.24M | -2.79M | -2.59M |
| Depreciation & Amortization | 287K | 149K | 17.22M | 402K | 13.01M | 10.41M | 6.95M | 2.87M | -1.23M | -699K | -1K | 20K | 43K | 3.25M | 615K | 164K | 192K | 2.43M | 3.06M | 2.52M | 1.61M | 123.76K | 55.23K | 52.01K |